Facebook's Zuckerberg Questioned in FTC Antitrust Probe

The Federal Trade Commission this week questioned Facebookfounder Mark Zuckerberg in its probe into whether the social-media giant has violated U.S. antitrust laws 


 
Bankrupt Valaris Meets With Opposition to Restructuring

Lenders took aim at Valaris's $7.1 billion restructuring plan at the London-based offshore contractor's debut chapter 11 hearing. 


 
Lyft, Uber Get More Time as They Fight California Order

Uber and Lyft will be able to continue conducting business as usual in California for now, after a state appeals court paused a lower-court ruling that required the ride-hailing companies to reclassify their drivers as employees. 


 
Bayer Settles Essure Birth-Control Litigation for $1.6 Billion

Bayer said it will pay $1.6 billion to settle claims that its birth-control device Essure causes serious health complications, the latest in a string of settlements by the German company. 


 
News Publishers Join Fight Against Apple Over App Store Terms

The New York Times and The Wall Street Journal are among companies seeking more favorable terms in Apple's app store. 


 
Volkswagen Notches Early Win in Legal Fight With SEC

A federal judge dismissed part of a civil fraud case against Volkswagen, a ruling that validated the company's claims that regulators piled on with a 2019 lawsuit over its emissions scandal. 


 
Dutch Retail Chain HEMA Seeks Protection From U.S. Creditors

Dutch department store chain HEMA B.V. has sought protection from its U.S. creditors to complete a financial restructuring in Europe that aims to trim about EUR400 million ($474 million) in debt from its balance sheet and help it withstand the coronavirus pandemic. 


 
CBS Seeking Over $5 Million for 2021 Super Bowl Ads

Ad buyers seek assurances they will be let out of their commitments in the event the game can't be played, sources say. 


 
Engaged Capital Targets Evolent Health

Activist investor Engaged Capital is taking aim at healthcare-software and services company Evolent Health, amassing a 9.9% stake and demanding changes to operations or alternatives including a potential sale, according to people familiar with the matter. 


 
Nvidia's Switch Hit

The three-year-old videogame console is still boosting the chip maker's revenue.